Frontlight ResearchEarly access
Trial site
Wenzhou Central Hospital
- 9running trials
- 3closed trials
The trials here
What the 12 trials at this site are about, from their registry records.
- Conditions
- Type 2 diabetes2 trials
- Atrial fibrillation1 trial
- Childhood cancers1 trial
- Gastric and oesophageal cancer1 trial
- IgA nephropathy1 trial
- Liver cirrhosis1 trial
- Metastatic breast cancer1 trial
- Parkinson disease1 trial
- Tuberculosis1 trial
- Phase
- Phase 33 trials
- Phase 42 trials
- Phase 21 trial
- Phase 2/31 trial
- Status
- Recruiting4 trials
- Completed3 trials
- Active, not recruiting2 trials
- Not yet recruiting2 trials
- Enrolling by invitation1 trial
- Lead sponsor
- Daiichi Sankyo2 trials
- Beijing Protgen Biotechnology Development Co., Ltd.1 trial
- First Affiliated Hospital of Zhejiang University1 trial
- Hangzhou PhecdaMed Co., Ltd.1 trial
- Huashan Hospital1 trial
- and 6 more
Running trials
Recruiting
Not yet recruiting
Recruiting
Stereotactic Thrombolysis With Tenecteplase for Supratentorial Intracerebral Hemorrhage
Enrolling by invitation
Explainable Machine Learning for Predicting Early Gastric Cancer
Active, not recruiting
Not yet recruiting
Recruiting
Recruiting
Microbiome and Host Susceptibility in Severe Pneumonia, a Prospective, Multicenter, Cohort Study
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Childhood cancers1 recruiting
- Gastric and oesophageal cancer1 recruiting
- Metastatic breast cancer1 recruiting
- Parkinson disease1 recruiting
- Type 2 diabetes1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 17 Nov 2026